Al-Maidan Clinic for Oral Health Services Company K.S.C.P. (KWSE:MIDAN)

KWSE:MIDAN Cash Flow Statement

Financials in millions KWD. Fiscal year is April - March.

Operating Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	10.65	9.52	9.27	11.82	12.18	10.28
Depreciation & Amortization	2.97	2.97	2.9	2.7	2.44	2.35
Loss (Gain) From Sale of Assets	-0.12	-0.12	0.01	-	-	-
Asset Writedown & Restructuring Costs	-0.01	-0.01	0.03	-	-0.02	2.16
Loss (Gain) From Sale of Investments	0.43	0.34	-1.27	-0.15	0.67	1.37
Loss (Gain) on Equity Investments	-0.89	-0.72	0.28	0.36	1.07	0.05
Provision & Write-off of Bad Debts	3.01	2.4	3.56	2.59	2.76	2.61
Other Operating Activities	-1.87	-2.22	-2.12	1.52	1.51	-0.31
Change in Accounts Receivable	1.85	2.67	-5.89	-3.5	-4.8	-1.31
Change in Inventory	-0.53	-0.88	0.1	-0.19	-0.03	-0.1
Change in Accounts Payable	-0.37	0.17	4.29	-0	2.22	4.62
Change in Other Net Operating Assets	-2.13	-2.33	-2.65	-0.71	-2.83	-0.34
Operating Cash Flow	12.98	11.78	8.52	14.43	15.17	21.38
Operating Cash Flow Growth	67.56%	38.19%	-40.93%	-4.87%	-29.07%	162.11%

Investing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-6.13	-6.08	-1.52	-1.85	-1.55	-1.44
Sale of Property, Plant & Equipment	0.17	0.17	0	-	-	-
Investment in Securities	-21.04	-20.24	-17.31	-4.9	1.3	-11
Other Investing Activities	2.05	2.15	1.97	-	-	-
Investing Cash Flow	-24.95	-24	-16.85	-6.75	-0.25	-12.44

Financing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Long-Term Debt Repaid	-	-0.69	-0.73	-0.79	-0.79	-0.81
Total Debt Repaid	-0.68	-0.69	-0.73	-0.79	-0.79	-0.81
Net Debt Issued (Repaid)	-0.68	-0.69	-0.73	-0.79	-0.79	-0.81
Issuance of Common Stock	-	-	-	-	0.01	-
Repurchase of Common Stock	-	-	-	-2.25	-2.5	-
Common Dividends Paid	-3.03	-3.03	-2.02	-1.12	-0	-2.49
Other Financing Activities	-0	-0.05	-0.01	-0.04	0.01	-
Financing Cash Flow	-3.72	-3.77	-2.76	-4.2	-3.27	-3.29

Net Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Cash Flow	-15.69	-15.99	-11.09	3.48	11.64	5.65

Free Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	6.84	5.7	7.01	12.57	13.62	19.94
Free Cash Flow Growth	5.46%	-18.66%	-44.28%	-7.64%	-31.72%	189.08%
Free Cash Flow Margin	10.80%	9.02%	9.73%	16.60%	18.75%	28.16%
Free Cash Flow Per Share	0.03	0.03	0.04	0.06	0.06	0.09
Levered Free Cash Flow	0.68	2.95	4.14	6.2	7.5	14.01
Unlevered Free Cash Flow	0.79	3.09	4.21	6.31	7.56	14.07

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	0	0.05	0.01	0.08	0.01	-
Cash Income Tax Paid	0.58	1.16	1.09	-	-	-
Change in Working Capital	-1.18	-0.38	-4.15	-4.4	-5.44	2.87

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 26, 2026

Data Sources Report a data error